A commentary flags that proposed updates to India’s laboratory animal regulation could set back the country’s emerging advanced-therapy ecosystem, including gene therapies and CAR-T programs. The draft Prevention of Cruelty to Animals rules (2026) from India’s Ministry of Fisheries, Animal Husbandry and Dairying is described as moving toward provisions that stakeholders say may compromise ethical standards and scientific credibility. The piece points to India’s recent regulatory milestones, including CDSCO approvals such as NexCAR19, and argues advanced therapies may need modernized animal-testing approaches rather than backwards-looking frameworks.